Pentasa is a brand name for mesalamine, an anti-inflammatory drug used to treat inflammatory bowel disease (IBD) like ulcerative colitis and Crohn’s disease. It belongs to the class of aminosalicylates. Pentasa is available in capsule form and should be taken orally four times a day. Shire US Inc., a global biotechnology company, markets the drug.